Invited Speakers:
|
|
Jeremy Barton, M.D. - Keynote Speaker Vice President, Oncology Biogen Idec Stephan Grant, Ph.D. - Featured Speaker Senior Director, Biochemistry and Primary Screening Pfizer Oncology
Cedo M. Bagi, Ph.D. Senior Research Fellow Pfizer
Haifeng Bao, Ph.D. RnD Translational Sciences MedImmune
Ronald K. Blackman, Ph.D. Director, Translational Biology Synta Pharmaceuticals
Dirk Brockstedt, Ph.D. Vice President, Research and Development Aduro BioTech
Jeffrey T. Finer, MD PhD Vice President, Discovery Five Prime Therapeutics, Inc.
Gadi Gazit-Bornstein, Ph.D. Principle Scientist AstraZeneca
Elena Izmailova, Ph.D. Associate Director, Molecular Medicine Millennium: The Takeda Oncology Company
Ravi Madan, M.D. Assistant Clinical Investigator Laboratory of Tumor Immunology and Biology Medical Oncology Branch National Cancer Institute
Karen McGovern, Ph.D. Director, Cancer Biology Infinity Pharmaceuticals
Melissa Paoloni, Ph.D. Staff Scientist Director, Comparative Oncology Trials Consortium National Cancer Institute, National Institutes of Health
Adam Pavlicek, Ph.D. Senior Principal Scientist Pfizer, Inc.
Jan Pinkas, Ph.D. Director ImmunoGen
Saileta Prabhu, Ph.D. Scientist Genentech
John Rothman, Ph.D. Executive Vice President, Science & Operation Advaxis
Mohammad Tabrizi, Ph.D. Vice President, Preclinical Development Anaptys Bio
Yinghui Zhou, Ph.D. Principal Scientist Aveo Pharmaceuticals
|
|